A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: Real-world practice
Số trang: 14
Loại file: pdf
Dung lượng: 1.81 MB
Lượt xem: 16
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efcacy and prognosis those two regimens as first-line treatment in real-world practice.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer KRAS mutation First-line treatment Antiangiogenic therapy Platinum-based chemotherapy Real-world practiceTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 173 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 144 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 121 0 0 -
12 trang 94 0 0
-
19 trang 75 0 0
-
17 trang 65 0 0
-
9 trang 45 0 0
-
12 trang 39 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 38 0 0